水腎症治療の世界市場 2020年

• 英文タイトル：Global Hydronephrosis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115622 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、水腎症治療の世界市場を調査対象にし、水腎症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（外科的治療、薬物治療）、用途別分析（病院、クリニック、外来手術センター）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：NephroGenex、Amgen、PHRAXIS、Novartis、Allergan、Sanofi、Anthem Group ・企業別売上、市場シェア ・水腎症治療の地域別市場分析 ・水腎症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・水腎症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・水腎症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・水腎症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・水腎症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・水腎症治療の種類別市場規模2015-2020：外科的治療、薬物治療 ・水腎症治療の用途別市場規模2015-2020：病院、クリニック、外来手術センター ・水腎症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Hydronephrosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hydronephrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hydronephrosis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hydronephrosis Treatment market has been segmented into:
Surgical Treatment
Drug Treatment

By Application, Hydronephrosis Treatment has been segmented into:
Hospital
Clinic
Ambulatory Surgery Centre

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hydronephrosis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Hydronephrosis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hydronephrosis Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Hydronephrosis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Hydronephrosis Treatment Market Share Analysis
Hydronephrosis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hydronephrosis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hydronephrosis Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Hydronephrosis Treatment are:
NephroGenex
Amgen
PHRAXIS
Novartis
Allergan
Sanofi
Anthem Group

レポート目次

---

Table of Contents

1 Hydronephrosis Treatment Market Overview
1.1 Product Overview and Scope of Hydronephrosis Treatment
1.2 Classification of Hydronephrosis Treatment by Type
1.2.1 Global Hydronephrosis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hydronephrosis Treatment Revenue Market Share by Type in 2019
1.2.3 Surgical Treatment
1.2.4 Drug Treatment
1.3 Global Hydronephrosis Treatment Market by Application
1.3.1 Overview: Global Hydronephrosis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Ambulatory Surgery Centre
1.4 Global Hydronephrosis Treatment Market by Regions
1.4.1 Global Hydronephrosis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hydronephrosis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hydronephrosis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hydronephrosis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hydronephrosis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hydronephrosis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hydronephrosis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 NephroGenex
2.1.1 NephroGenex Details
2.1.2 NephroGenex Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 NephroGenex SWOT Analysis
2.1.4 NephroGenex Product and Services
2.1.5 NephroGenex Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 PHRAXIS
2.3.1 PHRAXIS Details
2.3.2 PHRAXIS Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PHRAXIS SWOT Analysis
2.3.4 PHRAXIS Product and Services
2.3.5 PHRAXIS Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allergan SWOT Analysis
2.5.4 Allergan Product and Services
2.5.5 Allergan Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Anthem Group
2.7.1 Anthem Group Details
2.7.2 Anthem Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Anthem Group SWOT Analysis
2.7.4 Anthem Group Product and Services
2.7.5 Anthem Group Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hydronephrosis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hydronephrosis Treatment Players Market Share
3.2.2 Top 10 Hydronephrosis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hydronephrosis Treatment Revenue and Market Share by Regions
4.2 North America Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
5 North America Hydronephrosis Treatment Revenue by Countries
5.1 North America Hydronephrosis Treatment Revenue by Countries (2015-2020)
5.2 USA Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Hydronephrosis Treatment Revenue by Countries
6.1 Europe Hydronephrosis Treatment Revenue by Countries (2015-2020)
6.2 Germany Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hydronephrosis Treatment Revenue by Countries
7.1 Asia-Pacific Hydronephrosis Treatment Revenue by Countries (2015-2020)
7.2 China Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
8 South America Hydronephrosis Treatment Revenue by Countries
8.1 South America Hydronephrosis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hydronephrosis Treatment by Countries
9.1 Middle East & Africa Hydronephrosis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hydronephrosis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Hydronephrosis Treatment Market Forecast by Type (2019-2024)
10.3 Surgical Treatment Revenue Growth Rate (2015-2025)
10.4 Drug Treatment Revenue Growth Rate (2015-2025)
11 Global Hydronephrosis Treatment Market Segment by Application
11.1 Global Hydronephrosis Treatment Revenue Market Share by Application (2015-2020)
11.2 Hydronephrosis Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centre Revenue Growth (2015-2020)
12 Global Hydronephrosis Treatment Market Size Forecast (2021-2025)
12.1 Global Hydronephrosis Treatment Market Size Forecast (2021-2025)
12.2 Global Hydronephrosis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Hydronephrosis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hydronephrosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hydronephrosis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hydronephrosis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. NephroGenex Corporate Information, Location and Competitors
Table 6. NephroGenex Hydronephrosis Treatment Major Business
Table 7. NephroGenex Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. NephroGenex SWOT Analysis
Table 9. NephroGenex Hydronephrosis Treatment Product and Solutions
Table 10. NephroGenex Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Amgen Corporate Information, Location and Competitors
Table 12. Amgen Hydronephrosis Treatment Major Business
Table 13. Amgen Hydronephrosis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Amgen SWOT Analysis
Table 15. Amgen Hydronephrosis Treatment Product and Solutions
Table 16. Amgen Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. PHRAXIS Corporate Information, Location and Competitors
Table 18. PHRAXIS Hydronephrosis Treatment Major Business
Table 19. PHRAXIS Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. PHRAXIS SWOT Analysis
Table 21. PHRAXIS Hydronephrosis Treatment Product and Solutions
Table 22. PHRAXIS Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Hydronephrosis Treatment Major Business
Table 25. Novartis Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Hydronephrosis Treatment Product and Solutions
Table 28. Novartis Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Allergan Corporate Information, Location and Competitors
Table 30. Allergan Hydronephrosis Treatment Major Business
Table 31. Allergan Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Allergan SWOT Analysis
Table 33. Allergan Hydronephrosis Treatment Product and Solutions
Table 34. Allergan Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Hydronephrosis Treatment Major Business
Table 37. Sanofi Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Hydronephrosis Treatment Product and Solutions
Table 40. Sanofi Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Anthem Group Corporate Information, Location and Competitors
Table 42. Anthem Group Hydronephrosis Treatment Major Business
Table 43. Anthem Group Hydronephrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Anthem Group SWOT Analysis
Table 45. Anthem Group Hydronephrosis Treatment Product and Solutions
Table 46. Anthem Group Hydronephrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Hydronephrosis Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Hydronephrosis Treatment Revenue Share by Players (2015-2020)
Table 49. Global Hydronephrosis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Hydronephrosis Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Hydronephrosis Treatment Revenue by Countries (2015-2020)
Table 52. North America Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Hydronephrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Hydronephrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Hydronephrosis Treatment Revenue by Countries (2015-2020)
Table 56. South America Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Hydronephrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Hydronephrosis Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Hydronephrosis Treatment Revenue Share by Type (2015-2020)
Table 61. Global Hydronephrosis Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Hydronephrosis Treatment Revenue by Application (2015-2020)
Table 63. Global Hydronephrosis Treatment Revenue Share by Application (2015-2020)
Table 64. Global Hydronephrosis Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Hydronephrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hydronephrosis Treatment Picture
Figure 2. Global Hydronephrosis Treatment Revenue Market Share by Type in 2019
Figure 3. Surgical Treatment Picture
Figure 4. Drug Treatment Picture
Figure 5. Hydronephrosis Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Ambulatory Surgery Centre Picture
Figure 9. Global Hydronephrosis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hydronephrosis Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Hydronephrosis Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Hydronephrosis Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Hydronephrosis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Hydronephrosis Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Hydronephrosis Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Hydronephrosis Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Hydronephrosis Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Hydronephrosis Treatment Revenue Market Share by Countries in 2019
Figure 42. China Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Hydronephrosis Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Hydronephrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Hydronephrosis Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Hydronephrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Hydronephrosis Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Hydronephrosis Treatment Revenue Share by Type in 2019
Figure 59. Global Hydronephrosis Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Surgical Treatment Revenue Growth Rate (2015-2020)
Figure 61. Global Drug Treatment Revenue Growth Rate (2015-2020)
Figure 62. Global Hydronephrosis Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Hydronephrosis Treatment Revenue Share by Application in 2019
Figure 64. Global Hydronephrosis Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory Surgery Centre Revenue Growth Rate (2015-2020)
Figure 68. Global Hydronephrosis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Hydronephrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Hydronephrosis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Hydronephrosis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---